Mirjana Ziemer (M Ziemer)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Peritoneal Dialysis

Tyrosine Kinase

Gene Expression

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Svenja Holst, Anna K Weber, Friedegund Meier, Jörg Otte, Patrick Petzsch, Julia Reifenberger, Thorsten Wachtmeister, Dana Westphal, Mirjana Ziemer, Wasco Wruck, James Adjaye, Regina C Betz, Arno Rütten, Harald M Surowy, Silke Redler
Gene expression profiling in porocarcinoma indicates heterogeneous tumor development and substantiates poromas as precursor lesions. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG (2024)
N Kramer, G Müller, S Zierold, M Röckel, W Fröhlich, M Schefzyk, J Kumbrink, J C Hassel, C Berking, Mirjana Ziemer, D Nashan, Lars Einar French, J Vera, K E Kerl-French, R Gutzmer, L Heinzerling
Checkpoint inhibitor-induced bullous pemphigoid differs from spontaneous bullous pemphigoid. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (8) (2024)
Svenja Holst, Anna K Weber, Friedegund Meier, Jörg Otte, Patrick Petzsch, Julia Reifenberger, Thorsten Wachtmeister, Dana Westphal, Mirjana Ziemer, Wasco Wruck, James Adjaye, Regina C Betz, Arno Rütten, Harald M Surowy, Silke Redler
Gene expression profiling in porocarcinoma indicates heterogeneous tumor development and substantiates poromas as precursor lesions. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG (2024)
N Kramer, G Müller, S Zierold, M Röckel, W Fröhlich, M Schefzyk, J Kumbrink, J C Hassel, C Berking, Mirjana Ziemer, D Nashan, Lars Einar French, J Vera, K E Kerl-French, R Gutzmer, L Heinzerling
Checkpoint inhibitor-induced bullous pemphigoid differs from spontaneous bullous pemphigoid. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
N Kramer, G Müller, S Zierold, M Röckel, W Fröhlich, M Schefzyk, J Kumbrink, J C Hassel, C Berking, Mirjana Ziemer, D Nashan, Lars Einar French, J Vera, K E Kerl-French, R Gutzmer, L Heinzerling
Checkpoint inhibitor-induced bullous pemphigoid differs from spontaneous bullous pemphigoid. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (8) (2024)
Svenja Holst, Anna K Weber, Friedegund Meier, Jörg Otte, Patrick Petzsch, Julia Reifenberger, Thorsten Wachtmeister, Dana Westphal, Mirjana Ziemer, Wasco Wruck, James Adjaye, Regina C Betz, Arno Rütten, Harald M Surowy, Silke Redler
Gene expression profiling in porocarcinoma indicates heterogeneous tumor development and substantiates poromas as precursor lesions. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 22 (8) (2024)
Svenja Holst, Anna K Weber, Friedegund Meier, Jörg Otte, Patrick Petzsch, Julia Reifenberger, Thorsten Wachtmeister, Dana Westphal, Mirjana Ziemer, Wasco Wruck, James Adjaye, Regina C Betz, Arno Rütten, Harald M Surowy, Silke Redler
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 22 (8) (2024)
Mirjana Ziemer, Beate Weidenthaler-Barth, Philipp Gussek, Maja Pfeiffer, Johannes Kleemann, Katrin Bankov, Peter J Wild, Silke Seibold, Priyavathi Sureshkumar, Patricia Nickel, Anton Strobel, Markus Werner, Stephan Grabbe
Analytical Validation of an Immunohistochemical 7-Biomarker Prognostic Assay (immunoprint ® ) for Early-Stage Cutaneous Melanoma in Archival Tissue of Patients with AJCC v8 T2-T3 Disease. Diagnostics (Basel, Switzerland) 13 (19) (2023)
Robin Reschke, Konstantin Dumann, Mirjana Ziemer
Risk Stratification and Clinical Characteristics of Patients with Late Recurrence of Melanoma (>10 Years). Journal of clinical medicine 11 (7) (2022)
Alexander Thiem, Pegah Mashhadiakbar, Christiane Cussigh, Jessica C Hassel, Imke Grimmelmann, Ralf Gutzmer, Max Schlaak, Markus Vincent Heppt, Pia Dücker, Svea Hüning, Lena Schulmeyer, Bastian Schilling, Sebastian Haferkamp, Mirjana Ziemer, Rose K C Moritz, Victoria Hagelstein, Patrick Terheyden, Christian Posch, Maria R Gaiser, Peter Kropp, Steffen Emmert, Britta Müller, Julia K Tietze
Immune checkpoint inhibition and targeted therapy for melanoma: A patient-oriented cross-sectional comparative multicentre study. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Robin Reschke, Stephanie Zimmerlich, Christine Döhring, Gerhard Behre, Mirjana Ziemer
Effective Extracorporeal Photopheresis of Patients with Transplantation Induced Acute Intestinal GvHD and Bronchiolitis Obliterans Syndrome. Biomedicines 10 (8) (2022)
J Kohlmann, Robin Reschke, M Mockenhaupt, Mirjana Ziemer
Severe skin eruption with features of drug reaction with eosinophilia and systemic symptoms (DRESS) during vemurafenib treatment of melanoma. Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Robin Reschke, Philipp Gussek, Mirjana Ziemer
Identifying High-Risk Tumors within AJCC Stage IB-III Melanomas Using a Seven-Marker Immunohistochemical Signature. Cancers 13 (12) (2021)
Robin Reschke, Philipp Gussek, Andreas Boldt, Ulrich Sack, Ulrike Köhl, Florian Lordick, Thomas Gora, Markus Kreuz, Kristin Reiche, Jan-Christoph Simon, Mirjana Ziemer, Manfred Kunz
Distinct Immune Signatures Indicative of Treatment Response and Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor Therapy. International journal of molecular sciences 22 (15) (2021)